Philips Medical Systems recalls IQon Spectral CT IQon Spectral CT Upgrades
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- The clinical CT scan may not automatically trigger after the Bolus Tracking scan and may need to be triggered manually. Additional Bolus Tracking shots may occur. This may result in the clinical acquisition being inadequate for diagnosis, causing a potential for patient rescan and receiving additional radiation.
- Products
-
- IQon Spectral CT IQon Spectral CT Upgrades
- Company
- Philips Medical Systems
- Where it was sold
-
US Nationwide Distribution including Puerto Rico
Nationwide
- Units affected
- 42
- About this recall
- IQon Spectral CT IQon Spectral CT Upgrades